Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian LaBarre

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Bulletin of Mathematical Biology|June 28, 2018
Structural and Practical Identifiability Analysis of Zika Epidemiological ModelsNecibe Tuncer, Maia Marctheva, Brian LaBarre, et al.
Pediatric Blood & Cancer|May 1, 2024
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology GroupPrerna Kumar, Victoria W Willard, Leanne Embry, et al.
EJC Paediatric Oncology|January 17, 2025
Response to induction chemotherapy modifies the effect of conventional prognostic factors in high-risk neuroblastoma: A report from the Children's Oncology GroupElizabeth Sokol, Brian LaBarre, Navin Pinto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Patient- and proxy-reported quality of life in advanced dementia with Lewy bodiesMelissa J Armstrong, Brian LaBarre, Kaitlin Sovich, et al.
The American Journal of Surgical Pathology|March 19, 2021
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology GroupAsuka Kawano, Florette K Hazard, Bill Chiu, et al.
Cancer|January 13, 2026
A pilot study of chemoimmunotherapy in the postconsolidation setting for high-risk neuroblastoma (ANBL19P1): A report from the Children's Oncology GroupAmi V Desai, Arlene Naranjo, Brian LaBarre, et al.
Plos One|August 29, 2024
End-of-life experiences in individuals with dementia with Lewy bodies and their caregivers: A mixed-methods analysisEaston Wollney, Kaitlin Sovich, Brian LaBarre, et al.
Neurology. Clinical Practice|April 15, 2024
Caregiver Experiences and Burden in Moderate-Advanced Dementia With Lewy BodiesMelissa J Armstrong, Yunfeng Dai, Kaitlin Sovich, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2026
Does Pacemaker Mode Affect Outcomes in Patients With HeartMate 3 LVAD?Boaz Elad, Dor Lotan, Brian LaBarre, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Bulletin of Mathematical Biology|June 28, 2018
Structural and Practical Identifiability Analysis of Zika Epidemiological ModelsNecibe Tuncer, Maia Marctheva, Brian LaBarre, et al.
Pediatric Blood & Cancer|May 1, 2024
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology GroupPrerna Kumar, Victoria W Willard, Leanne Embry, et al.
EJC Paediatric Oncology|January 17, 2025
Response to induction chemotherapy modifies the effect of conventional prognostic factors in high-risk neuroblastoma: A report from the Children's Oncology GroupElizabeth Sokol, Brian LaBarre, Navin Pinto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Patient- and proxy-reported quality of life in advanced dementia with Lewy bodiesMelissa J Armstrong, Brian LaBarre, Kaitlin Sovich, et al.
The American Journal of Surgical Pathology|March 19, 2021
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology GroupAsuka Kawano, Florette K Hazard, Bill Chiu, et al.
Cancer|January 13, 2026
A pilot study of chemoimmunotherapy in the postconsolidation setting for high-risk neuroblastoma (ANBL19P1): A report from the Children's Oncology GroupAmi V Desai, Arlene Naranjo, Brian LaBarre, et al.
Plos One|August 29, 2024
End-of-life experiences in individuals with dementia with Lewy bodies and their caregivers: A mixed-methods analysisEaston Wollney, Kaitlin Sovich, Brian LaBarre, et al.
Neurology. Clinical Practice|April 15, 2024
Caregiver Experiences and Burden in Moderate-Advanced Dementia With Lewy BodiesMelissa J Armstrong, Yunfeng Dai, Kaitlin Sovich, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 29, 2026
Does Pacemaker Mode Affect Outcomes in Patients With HeartMate 3 LVAD?Boaz Elad, Dor Lotan, Brian LaBarre, et al.
Pageof 2